معرفی
Elizabeth Fixman is an Associate Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), Glen site. She leads the Translational Research in Respiratory Diseases Program at the Centre for Translational Biology, conducting research at the Meakins-Christie Laboratories.
Education
- BSc in Chemistry/Biochemistry from Colorado State University (1986)
- PhD in Pharmacology from Johns Hopkins University (1992)
Research Focus
Dr. Fixman's research employs murine models to investigate innate and adaptive immune coordination in type 2 inflammation within allergic airways disease. Key areas include: IL-33 and RSV activation of lung innate cells, STAT6 pathways in eosinophils, immunomodulatory peptide development (STAT6-IP), and sex hormone influences on inflammatory responses. Her work bridges immunology, respiratory pathophysiology, and therapeutic innovation.
Publication Trends
Her recent publications (2013-2024) demonstrate consistent focus on STAT6 signaling pathways, sex-based differences in immune responses, dendritic cell migration mechanisms, and novel peptide therapeutics. Research utilizes murine models to explore neonatal immunity, viral reinfection outcomes, and cellular metabolism in immune regulation, with translational applications for asthma and allergic diseases.
Teaching and Laboratory
She teaches 'Advanced Topics in Respiration' (EXMD 508) and leads a laboratory at the RI-MUHC Glen site investigating immunological mechanisms in respiratory diseases.
